Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K. Yamada T, et al. Among authors: yoshiyama k. Int J Oncol. 2015 Jan;46(1):55-62. doi: 10.3892/ijo.2014.2699. Epub 2014 Oct 7. Int J Oncol. 2015. PMID: 25310280 Clinical Trial.
Nonmalignant pericardial effusion associated with thymic cancer.
Nishi T, Takamori S, Muta F, Yoshiyama K, Iwasaki Y, Shirouzu K. Nishi T, et al. Among authors: yoshiyama k. Gen Thorac Cardiovasc Surg. 2010 May;58(5):239-42. doi: 10.1007/s11748-009-0506-1. Epub 2010 May 7. Gen Thorac Cardiovasc Surg. 2010. PMID: 20449715
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T. Terazaki Y, et al. Among authors: yoshiyama k. Cancer Sci. 2012 Apr;103(4):638-44. doi: 10.1111/j.1349-7006.2012.02202.x. Epub 2012 Feb 13. Cancer Sci. 2012. PMID: 22321067 Free PMC article. Clinical Trial.
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T. Sakamoto S, et al. Among authors: yoshiyama k. Hum Vaccin Immunother. 2015;11(12):2784-9. doi: 10.1080/21645515.2015.1075107. Hum Vaccin Immunother. 2015. PMID: 26325075 Free PMC article.
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T. Sakamoto S, et al. Among authors: yoshiyama k. Clin Lung Cancer. 2017 Nov;18(6):e385-e394. doi: 10.1016/j.cllc.2017.03.011. Epub 2017 Mar 24. Clin Lung Cancer. 2017. PMID: 28416261 Free article. Clinical Trial.
142 results